Territorial Availability: Available through Bertin Technologies only in France
- Synonyms
- 3E-[2-[(1R,4aS,5R,6R,8aS)-decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl]ethylidene]dihydro-4S-hydroxy-2(3H)-furanone
- Correlated keywords
- andrographis andrographolid 5953-53-7 101060-34-8 diterpenoids medicinal plants immunosuppression antithrombosis anti-inflammatory anti-inflammatory anti inflammatory antineoplastic anti-neoplastic neoplastic anti-viral antiviral viral anti-bacterial antibacterial bacterial anti-diabetic antidiabetic diabetics anti-oxidative stress antioxidative oxiddative antipyretic anti-pyretic pyretic anti-oedematogenic antioedematogenic anti-nociceptive antinociceptive nociceptive nuclear factor kappa B NF-?B p50 CYP1A endothelial cells E-selectin neutrophils allergic inflammations asthma CYP450 eselectin E selectin signaling signalling Andrographis paniculata inhibits inhibition inhibitors NF?B NF ?B DNA anti-edematogenic antiedematogenic
- Product Overview:
Andrographolide is a labdane diterpenoid that is the main bioactive component of A. paniculata, a well-recognized medicinal plant in Asia. It exerts a wide range of therapeutic actions, including immunosuppressant, antithrombotic, anti-inflammatory, antineoplastic, antiviral, antibacterial, antidiabetic, antioxidative stress, antipyretic, antioedematogenic, and antinociceptive activities.{21112} Andrographolide treatment inhibits nuclear factor kappa B (NF-?B) binding to DNA promoters of target genes (IC50 = ~15 ?M), by forming a covalent adduct with reduced cysteine (62) of the NF-?B p50 subunit, and can also induce expression of the CYP1A subfamily of the cytochrome P450 family of enzymes.{21113,21111} At 5 ?g/g body weight it can suppress the activation of NF-?B in stimulated endothelial cells, reducing the expression of the cell adhesion molecule E-selectin, abrogating the cytokine- and endotoxin-induced peritoneal infiltration of neutrophils, attenuating septic shock, and preventing allergic lung inflammation in a mouse model of asthma.{21111}
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.